Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
ImmunityBio, Inc.
Indaptus Therapeutics, Inc
Hoffmann-La Roche
Incyte Corporation
NeoTX Therapeutics Ltd.
City of Hope Medical Center
BioInvent International AB
Exelixis
Cancer Research UK
Regeneron Pharmaceuticals
Carisma Therapeutics Inc
Salubris Biotherapeutics Inc
ImmunoVaccine Technologies, Inc. (IMV Inc.)